Risk factors associated with early postpartum glucose intolerance in women with a history of gestational diabetes mellitus: a systematic review and meta-analysis
Abstract
Purpose This meta-analysis was aimed at exploring the incidence and risk factors of glucose intolerance in women with gestational diabetes mellitus (GDM) at 6-12 weeks postpartum to inform the development of preventive strategies. Method We searched Pubmed, Embase, Web of Science, the Cochrane Library, Ovid, China Knowledge Resource Integrated Database (CNKI), Wanfang Database and China Biology Medicine Database for entries between January 1990 and September 2022. The search terms included gestational diabetes mellitus, postpartum, glucose intolerance and type 2 diabetes. The meta-analysis was conducted using Stata 14.0. Result We included 37 studies, with 21 and 16 having low and medium risk of bias, respectively. The incidence of glucose intolerance in women with GDM 6-12 weeks postpartum was 27% (95% CI: 0.22-0.33). The following risk factors for GDM 6-12 weeks postpartum were identified: insulin use during pregnancy (OR = 3.23; 95% CI: 2.35-4.44), family history of diabetes (OR = 2.94; 95% CI: 1.98-4.33), abnormal fasting glucose levels at 24-28 weeks of gestation (OR = 1.15; 95% CI: 1.07-1.25), high pre-pregnancy BMI (OR = 1.63; 95% CI: 1.23-2.15), abnormal triglyceride levels during 28-40 weeks of gestation (OR = 2.18; 95% CI: 1.18-4.03), abnormal HbA 1 c levels at 28-40 weeks of gestation (OR = 6.62; 95% CI: 4.71-9.30), history of previous GDM (OR = 2.11; 95% CI: 1.27-3.49), and high 1-h glucose levels at 24-28 weeks of gestation (OR = 1.16; 95% CI:1.06-1.28). Conclusi…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
GDM is often indicative of underlying beta-cell dysfunction, which confers marked increased risk for later development of glucose intolerance and diabetes in the mother after delivery.
“GDM is often indicative of underlying b-cell dysfunction (182), which confers marked increased risk for later development of glucose intolerance and diabetes in the mother after delivery (183-185).”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [185]
Cites
2. Classification and Diagnosis of Diabetes: <i>Standards of Medical Care in Diabetes—2022</i>
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792 · see citing works
Criteria for screening tests for gestational diabetes
Carpenter, M. W., & Coustan, D. R. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90349-0 · Cited by 1,924 · see citing works
Cho, Y. M., Kim, T. H., Lim, S., Choi, S. H., Shin, H. D., Lee, H. K., Park, K. S., & Jang, H. C. (2009) · Diabetologia · doi:10.1007/s00125-008-1196-4 · Cited by 243 · see citing works
Glucose Intolerance after a Recent History of Gestational Diabetes Based on the 2013 WHO Criteria
Benhalima, K., Jegers, K., Devlieger, R., Verhaeghe, J., & Mathieu, C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0157272 · Cited by 45 · see citing works
Benhalima, K., Van Crombrugge, P., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., De Block, C., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8030383 · Cited by 33 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393 · see citing works
- Authors
- Liu, Z., Zhang, Q., Liu, L., & Liu, W.
- Affiliations
- Capital Medical University (CN)
- Corresponding author
- Liu, Weiwei
- Venue
- Endocrine
- Published
- 2023-08-16
- Volume
- 82
- Issue
- 3
- Pages
- 498-512
- ISSN
- 0969-711X (ISSN-L)
- 1559-0100
- OpenAlex
- W4385858190
- Cited by
- 22
- References
- 5
- Citations by year
- 2026: 10 · 2025: 5 · 2024: 6 · 2023: 1
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Endocrine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (71904133)
- Medjaden Academy & Research Foundation for Young Scientists (No. MJA202306038)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- gestational diabetes mellitus, postpartum glucose intolerance, type 2 diabetes risk, risk factors, family history of diabetes, pre-pregnancy body mass index, triglycerides, HbA1c, fasting blood glucose, incidence, prevention, women's health, pregnancy outcomes, postpartum period, glycemic control in pregnancy, postpartum follow-up
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Type 2, Female, Glucose, Glucose Tolerance Test, Humans, Pregnancy, Risk Factors, Diabetes, Gestational, Glucose Intolerance, Postpartum Period
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review